India · Delayed Price · Currency is INR Aurobindo Pharma Statistics
Total Valuation
BOM:524804 has a market cap or net worth of INR 909.21 billion. The enterprise value is 883.68 billion.
| Market Cap | 909.21B |
| Enterprise Value | 883.68B |
Important Dates
The next confirmed earnings date is Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | Aug 8, 2025 |
Share Statistics
| Current Share Class | 575.38M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.35% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 15.36% |
| Owned by Institutions (%) | 31.46% |
| Float | 273.51M |
Valuation Ratios
The trailing PE ratio is 25.94 and the forward PE ratio is 20.15.
| PE Ratio | 25.94 |
| Forward PE | 20.15 |
| PS Ratio | 2.70 |
| PB Ratio | 2.40 |
| P/TBV Ratio | 2.79 |
| P/FCF Ratio | 32.01 |
| P/OCF Ratio | 16.45 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.89, with an EV/FCF ratio of 31.11.
| EV / Earnings | 25.21 |
| EV / Sales | 2.63 |
| EV / EBITDA | 12.89 |
| EV / EBIT | 17.40 |
| EV / FCF | 31.11 |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.81 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.18 |
| Debt / FCF | 2.84 |
| Interest Coverage | 13.22 |
Financial Efficiency
Return on equity (ROE) is 9.93% and return on invested capital (ROIC) is 10.05%.
| Return on Equity (ROE) | 9.93% |
| Return on Assets (ROA) | 5.86% |
| Return on Invested Capital (ROIC) | 10.05% |
| Return on Capital Employed (ROCE) | 12.55% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 12.15M |
| Profits Per Employee | 1.26M |
| Employee Count | 27,707 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 1.19 |
Taxes
In the past 12 months, BOM:524804 has paid 16.09 billion in taxes.
| Income Tax | 16.09B |
| Effective Tax Rate | 31.47% |
Stock Price Statistics
The stock price has increased by +36.50% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +36.50% |
| 50-Day Moving Average | 1,512.83 |
| 200-Day Moving Average | 1,308.78 |
| Relative Strength Index (RSI) | 57.23 |
| Average Volume (20 Days) | 34,395 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524804 had revenue of INR 336.53 billion and earned 35.05 billion in profits. Earnings per share was 60.34.
| Revenue | 336.53B |
| Gross Profit | 201.65B |
| Operating Income | 50.78B |
| Pretax Income | 51.12B |
| Net Income | 35.05B |
| EBITDA | 68.56B |
| EBIT | 50.78B |
| Earnings Per Share (EPS) | 60.34 |
Balance Sheet
The company has 106.18 billion in cash and 80.73 billion in debt, with a net cash position of 25.45 billion.
| Cash & Cash Equivalents | 106.18B |
| Total Debt | 80.73B |
| Net Cash | 25.45B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 378.83B |
| Book Value Per Share | 652.31 |
| Working Capital | 146.70B |
Cash Flow
In the last 12 months, operating cash flow was 55.26 billion and capital expenditures -26.86 billion, giving a free cash flow of 28.41 billion.
| Operating Cash Flow | 55.26B |
| Capital Expenditures | -26.86B |
| Depreciation & Amortization | 17.78B |
| Net Borrowing | -6.93B |
| Free Cash Flow | 28.41B |
| FCF Per Share | n/a |
Margins
Gross margin is 59.92%, with operating and profit margins of 15.09% and 10.41%.
| Gross Margin | 59.92% |
| Operating Margin | 15.09% |
| Pretax Margin | 15.19% |
| Profit Margin | 10.41% |
| EBITDA Margin | 20.37% |
| EBIT Margin | 15.09% |
| FCF Margin | 8.44% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.25%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 0.25% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 6.63% |
| Buyback Yield | 0.35% |
| Shareholder Yield | 0.60% |
| Earnings Yield | 3.85% |
| FCF Yield | 3.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:524804 is 1,570.83, which is -0.54% lower than the current price. The consensus rating is "Buy".
| Price Target | 1,570.83 |
| Price Target Difference | -0.54% |
| Analyst Consensus | Buy |
| Analyst Count | 28 |
| Revenue Growth Forecast (3Y) | 12.18% |
| EPS Growth Forecast (3Y) | 17.77% |
Stock Splits
The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Jul 20, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |